XML 46 R13.htm IDEA: XBRL DOCUMENT v3.7.0.1
Goodwill and Intangible Assets
12 Months Ended
Mar. 31, 2017
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Intangible Assets
Intangible Assets and Software Development Costs





The following table summarizes our intangible assets and software development costs at March 31, 2017, and 2016:
 
2017
 
2016
 
Gross
 
Net
 
Gross
 
Net
 
carrying
Accumulated
carrying
 
carrying
Accumulated
carrying
(In thousands)
amount
amortization
amount
 
amount
amortization
amount
Amortized intangible assets:
 
 
 
 
 
 
 
Customer relationships
$
10,775

$
(10,775
)
$

 
$
10,775

$
(10,775
)
$

Non-competition agreements
2,700

(2,700
)

 
2,700

(2,700
)

Developed technology
10,660

(10,398
)
262

 
10,660

(10,398
)
262

Accumulated impairment
(262
)
 N/A

(262
)
 
(262
)
N/A

(262
)
Trade names
230

(100
)
130

 
230

(54
)
176

Patented technology
80

(80
)

 
80

(80
)

 
24,183

(24,053
)
130

 
24,183

(24,007
)
176

Indefinite-lived intangible assets:
 
 
 
 
 
 
 
Trade names
9,200

 N/A

9,200

 
9,200

  N/A

9,200

Accumulated impairment
(570
)
 N/A

(570
)
 
(570
)
  N/A

(570
)
Finite life reclassification
(230
)
 N/A

(230
)
 
(230
)
N/A

(230
)
 
8,400

 N/A

8,400

 
8,400

 N/A

8,400

Total intangible assets
$
32,583

$
(24,053
)
$
8,530

 
$
32,583

$
(24,007
)
$
8,576

 
 
 
 
 
 
 
 
Software development costs
$
47,989

$
(10,356
)
$
37,633

 
$
6,359

$
(2,344
)
$
4,015

Project expenditures not yet in use
10,757


10,757

 
40,536


40,536

Accumulated impairment
(1,391
)
 N/A

(1,391
)
 
(1,391
)
 N/A

(1,391
)
Total software development costs
$
57,355

$
(10,356
)
$
46,999

 
$
45,504

$
(2,344
)
$
43,160

 
 
 
 
 
 
 
 


Indefinite-lived intangible assets, comprised of our purchased trade name InfoGenesis™ as of March 31,2017 and 2016 are tested for impairment upon identification of impairment indicators, at least annually. An impairment loss is recognized if the carrying amount is greater than fair value. . The InfoGenesis™ indefinite-lived purchased trade name impairment testing resulted in a fair value exceeding the carrying amount for the years ending March 31, 2017, 2016 and 2015.

During the fourth quarter of fiscal 2015, certain restructuring activities incurred to better align product development, sales and marketing and general and administrative functions impacted the expected remaining useful life of the products under the Eatec® trade name. The trade name was determined to have a finite life and subsequently written down to its fair value to be amortized over five years. The fair value of this trade name was calculated based on future cash flows over the remaining useful life resulting in an impairment charge of $0.6 million for the year ended March 31, 2015. This charge is classified within "Impairments and other fair value adjustments" in the Consolidated Statements of Operations.

At each balance sheet date, the unamortized capitalized software development costs for external use is compared to the net realizable value of that product by analyzing critical inputs such as costs necessary to bring the software to market, life of the software, and market capacity. The amount by which unamortized software costs exceeds the net realizable value, if any, is recognized as a charge to income in the period it is determined. As of March 31, 2016, we determined that the remaining net book value of our acquired developed technology WMx®™ exceeded its net realizable value resulting in an impairment charge of $0.3 million. Additionally, as of March 31, 2015, we determined that the remaining net book value of our InfoGenesis Mobile (IG Mobile) software exceeded its net realizable value resulting in an impairment charge of $1.4 million. These charges are classified within "Impairments and other fair value adjustments" in the Consolidated Statements of Operations.

The following table summarizes our remaining estimated amortization expense relating to in service intangible assets and software development costs.
 
Estimated
 
Amortization
(In thousands)
Expense
Fiscal year ending March 31,
 
2018
$
9,272

2019
9,150

2020
8,411

2021
8,326

2022
1,083

Total
$
36,242



Amortization expense related to software development costs related to assets to be sold, leased, or otherwise marketed was $8.0 million, $1.0 million and $1.3 million for the fiscal years ended March 31, 2017, 2016 and 2015, respectively. These charges are included as Products cost of goods sold within the Consolidated Statements of Operations. Amortization expense relating to other definite-lived intangible assets was $46,000, $46,000, and $0.9 million for the fiscal years ended March 31, 2017, 2016 and 2015, respectively. These charges are classified as operating expenses within the Consolidated Statements of Operations.

Capitalized software development costs are carried on our balance sheet at net realizable value, net of accumulated amortization. We capitalized approximately $11.9 million, $13.3 million and $17.2 million during fiscal 2017, 2016 and 2015, respectively.